Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome. (2007)

Peer-Reviewed Study · Almeida JA, Riordan SM, Liu J, Galhenage S, Kim R, Bihari D, Wegner EA, Cranney GB, Thomas PS · April 2007

Almeida JA et al., 2007-04: Counter-case report: a 46-year-old with Child-Pugh C cirrhosis and chronic hepatopulmonary syndrome who deteriorated when the nitric oxide pathway was inhibited, with the authors advising against it.

suggest that inhibition of the nitric oxide-cyclic guanosine monophosphate pathway should be avoided in this setting

Almeida JA et al., 2007-04: Counter-case report: a 46-year-old with Child-Pugh C cirrhosis and chronic hepatopulmonary syndrome who deteriorated when the nitric oxide pathway was inhibited, with the authors advising against it. C10 (contrary, recorded at full strength). Study type: single case report; Gastrointestinal and Liver Unit, Prince of Wales Hospital, Sydney, Australia. N=1, female, 46 years, Child-Pugh class C cirrhosis, 12 months of progressive dyspnoea. The authors conclude that inhibition of the NO-cGMP pathway 'should be avoided in this setting' because of the possibility of substantial worsening of pulmonary oxygen exchange. Dose not applicable (the abstract does not give a methylene-blue dose); the case is the direct counterweight to MTI-103. Eur J Gastroenterol Hepatol 2007;19:341-346. Study type: case report.